- $48.71bn
- $47.00bn
- $17.40bn
- 94
- 49
- 44
- 67
Annual income statement for Corteva, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 8-K |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 15,655 | 17,455 | 17,226 | 16,908 | 17,401 |
| Cost of Revenue | |||||
| Gross Profit | 6,435 | 7,019 | 7,306 | 7,379 | 8,229 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 14,606 | 15,872 | 15,631 | 15,184 | 14,963 |
| Operating Profit | 1,049 | 1,583 | 1,595 | 1,724 | 2,438 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 2,346 | 1,426 | 1,093 | 1,275 | 1,688 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 1,822 | 1,216 | 941 | 863 | 1,204 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 1,759 | 1,147 | 735 | 907 | 1,094 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 1,759 | 1,147 | 735 | 907 | 1,094 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 2.87 | 2.06 | 1.92 | 1.64 | 2.58 |
| Dividends per Share |